The aim of REPAIR Impact Fund is to increase humanity’s therapeutic arsenal in the fight against antimicrobial resistance.
Novo Holdings established the REPAIR Impact Fund commissioned by the Novo Nordisk Foundation in February 2018 to invest in companies involved in discovering and the early-stage development of therapies targeting resistant microorganisms.REPAIR is an acronym: Replenishing and Enabling the Pipeline for Anti-Infective Resistance.The Novo Nordisk Foundation is commissioning the initiative, and Novo Holdings is executing it.